Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 11;15(8):e0237419.
doi: 10.1371/journal.pone.0237419. eCollection 2020.

Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19

Affiliations

Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19

Lara Jehi et al. PLoS One. .

Abstract

Background: Coronavirus Disease 2019 is a pandemic that is straining healthcare resources, mainly hospital beds. Multiple risk factors of disease progression requiring hospitalization have been identified, but medical decision-making remains complex.

Objective: To characterize a large cohort of patients hospitalized with COVID-19, their outcomes, develop and validate a statistical model that allows individualized prediction of future hospitalization risk for a patient newly diagnosed with COVID-19.

Design: Retrospective cohort study of patients with COVID-19 applying a least absolute shrinkage and selection operator (LASSO) logistic regression algorithm to retain the most predictive features for hospitalization risk, followed by validation in a temporally distinct patient cohort. The final model was displayed as a nomogram and programmed into an online risk calculator.

Setting: One healthcare system in Ohio and Florida.

Participants: All patients infected with SARS-CoV-2 between March 8, 2020 and June 5, 2020. Those tested before May 1 were included in the development cohort, while those tested May 1 and later comprised the validation cohort.

Measurements: Demographic, clinical, social influencers of health, exposure risk, medical co-morbidities, vaccination history, presenting symptoms, medications, and laboratory values were collected on all patients, and considered in our model development.

Results: 4,536 patients tested positive for SARS-CoV-2 during the study period. Of those, 958 (21.1%) required hospitalization. By day 3 of hospitalization, 24% of patients were transferred to the intensive care unit, and around half of the remaining patients were discharged home. Ten patients died. Hospitalization risk was increased with older age, black race, male sex, former smoking history, diabetes, hypertension, chronic lung disease, poor socioeconomic status, shortness of breath, diarrhea, and certain medications (NSAIDs, immunosuppressive treatment). Hospitalization risk was reduced with prior flu vaccination. Model discrimination was excellent with an area under the curve of 0.900 (95% confidence interval of 0.886-0.914) in the development cohort, and 0.813 (0.786, 0.839) in the validation cohort. The scaled Brier score was 42.6% (95% CI 37.8%, 47.4%) in the development cohort and 25.6% (19.9%, 31.3%) in the validation cohort. Calibration was very good. The online risk calculator is freely available and found at https://riskcalc.org/COVID19Hospitalization/.

Limitation: Retrospective cohort design.

Conclusion: Our study crystallizes published risk factors of COVID-19 progression, but also provides new data on the role of social influencers of health, race, and influenza vaccination. In a context of a pandemic and limited healthcare resources, individualized outcome prediction through this nomogram or online risk calculator can facilitate complex medical decision-making.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. This figure shows the cumulative incidence of each of the 3 outcomes (going home; transferred to ICU; death) following hospitalization in our COVID-19 cohort.
Values above the days from admission axis indicate numbers of patients at risk.
Fig 2
Fig 2. A nomogram (graphical version of the model) is shown.
Line 1 is used to calculate the points that are associated with each of the predictor variables. Each subsequent line represents a predictor in the final model. The patient’s characteristic is found on each line, and from it, a vertical line is drawn to find the points that are associated with each value. All the points are then totaled and located on second to last line. A vertical line is drawn down to the bottom line to locate the predicted risk of hospitalization produced by the model.
Fig 3
Fig 3. Online risk calculator for risk of hospitalization from COVID-19, found at https://riskcalc.org/COVID19Hospitalization/.
The example here is a 55-year-old white male, former smoker, who presented with cough, shortness of breath, and loss of appetite. He has diabetes and received no vaccinations this year and is only on NSAIDs for some chronic joint pains. No labs are available yet. His predicted risk of hospitalization is 8.56%. If race is changed to Black, with all other variables remaining constant, his relative risk almost doubles to an absolute value of 17.22%.
Fig 4
Fig 4. Calibration curve for the model predicting likelihood of hospitalization.
The x-axis displays the predicted probabilities generated by the statistical model and the y-axis shows the fraction of the patients with COVID-19 who were hospitalized at the given predicted probability. The 45° line, therefore, indicates perfect calibration where, for example, at a predicted probability of 0.2 is associated with an actual observed proportion of 0.2. The solid black line indicates the model’s relationship with the outcome. The closer the line is to the 45-degree line, the closer the model’s predicted probability is to the actual proportion. As demonstrated, there is excellent correspondence between the predicted probability of a positive test and the observed frequency of hospitalization in COVID-19 (+) patients.

References

    1. Tsai T, Jacobson B, Jha A. American Hospital Capacity And Projected Need for COVID-19 Patient Care. Health Affairs. https://www.healthaffairs.org/do/10.1377/hblog20200317.457910/full/ accessed April 10, 2020. - DOI
    1. Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020. March 19. pii: S0163-4453(20)30119-5. - PMC - PubMed
    1. Zhou F, Yu T, Du R, Fan G et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054 Epub 2020 Mar 11. 10.1016/S0140-6736(20)30566-3 - DOI - PMC - PubMed
    1. Liu W, Tao ZW, Lei W, Ming-Li Y, Kui L, Ling Z, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020. February 28 10.1097/CM9.0000000000000775 [Epub ahead of print] . - DOI - PMC - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020. - PubMed

Publication types

MeSH terms